Trial Profile
Non-interventional, Observational Study of the Application of Zomacton in the Treatment of Growth Hormone Deficiency in Routine Clinical Practice.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Short stature; Somatotropin deficiency
- Focus Therapeutic Use
- Sponsors Ferring Pharmaceuticals
- 30 Apr 2015 New trial record